Ribomic Inc. (4591.T)
JPY 80.0
(0.0%)
JPY 80.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.27 Million JPY | 9.86% |
| 2022 | 2.07 Million JPY | -14.14% |
| 2021 | 2.41 Million JPY | -20.64% |
| 2020 | 3.03 Million JPY | -49.37% |
| 2019 | 6 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1 Million JPY | -56.02% |
| 2023 Q4 | 2.27 Million JPY | -15.24% |
| 2023 Q3 | 2.68 Million JPY | 15.8% |
| 2023 Q2 | 2.31 Million JPY | 37.34% |
| 2023 Q1 | 1.68 Million JPY | -18.5% |
| 2023 FY | 2.27 Million JPY | 9.86% |
| 2022 Q3 | 2.65 Million JPY | 25.39% |
| 2022 Q2 | 2.11 Million JPY | 0.0% |
| 2022 Q4 | 2.07 Million JPY | -22.09% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 99.667% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | 87.317% |
| GNI Group Ltd. | 2.33 Billion JPY | 99.902% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 99.898% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 96.63% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 99.797% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 97.804% |
| AnGes, Inc. | 1.61 Billion JPY | 99.859% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 96.927% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 99.922% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 99.294% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -1135.87% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 98.377% |
| CanBas Co., Ltd. | 728 Thousand JPY | -212.363% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 97.412% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 98.463% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 96.453% |
| Kidswell Bio Corporation | 875.65 Million JPY | 99.74% |
| PeptiDream Inc. | 2.4 Billion JPY | 99.905% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | 57.432% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -227399900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | 93.683% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | 92.159% |
| CellSource Co., Ltd. | 305.92 Million JPY | 99.257% |
| FunPep Company Limited | 25.54 Million JPY | 91.097% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 99.375% |
| Stella Pharma Corporation | 1.11 Billion JPY | 99.796% |
| TMS Co., Ltd. | 50.02 Million JPY | 95.454% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | 89.12% |
| Cuorips Inc. | 1.04 Million JPY | -118.025% |
| K Pharma,Inc. | 10.79 Million JPY | 78.933% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.981% |
| ReproCELL Incorporated | 248.14 Million JPY | 99.084% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 99.495% |
| StemCell Institute Inc. | 42.26 Million JPY | 94.619% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 99.005% |
| CellSeed Inc. | 46.19 Million JPY | 95.077% |